FindMyRecallSubscribe
Class I: serious health riskTerminated

Cubist Pharmaceuticals Cubicin Recall

Cubicin (daptomycin for injection), 500 mg lyophilized powder, 10 mL single-use vials,…

Cubist Pharmaceuticals, Inc. · Lexington, MA

Risk level
Class I
Reported by FDA
Jan 29, 2014
Recall ID
D-764-2014
Check your lot numberHow we source this data

Summary

Cubist Pharmaceuticals recalled Cubicin starting Aug 29, 2013. The FDA classified it as Class I (serious health risk) and published enforcement report D-764-2014 on Jan 29, 2014. Reason: Presence of Particulate Matter; Glass particulates observed in vials. Status: Terminated.

Why it was recalled

Presence of Particulate Matter; Glass particulates observed in vials

Product description

Cubicin (daptomycin for injection), 500 mg lyophilized powder, 10 mL single-use vials, Rx only, Manufactured for Cubist Pharmaceuticals, Inc., Lexington, MA

Lot numbers, UPCs & expiration codes

Lot Numbers: Lot 950453F, Exp. 12/06/2013 Lot 090203F, Exp. 09/07/2014 Lot 201703F, Exp. 08/31/2015 Lot 201653F, Exp. 09/01/2015

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-764-2014
Classification
Class I
Status
Terminated
Recall initiated
Aug 29, 2013
FDA report date
Jan 29, 2014
Quantity
179,870 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Cubist Pharmaceuticals, Inc.

Original FDA data

Every field from FDA enforcement report D-764-2014, exactly as published.

Show all FDA fields
City
Lexington
State
MA
Status
Terminated
Country
United States
Event ID
66041
Address
65 Hayden Avenue
Code information
Lot Numbers: Lot 950453F, Exp. 12/06/2013 Lot 090203F, Exp. 09/07/2014 Lot 201703F, Exp. 08/31/2015 Lot 201653F, Exp. 09/01/2015
Postal code
02421-7994
Report date
Jan 29, 2014
Product type
Drugs
Recall number
D-764-2014
Classification
Class I
Recalling firm
Cubist Pharmaceuticals, Inc.
Product quantity
179,870 vials
Termination date
Feb 10, 2015
Reason for recall
Presence of Particulate Matter; Glass particulates observed in vials
Voluntary / mandated
Voluntary: Firm initiated
Product description
Cubicin (daptomycin for injection), 500 mg lyophilized powder, 10 mL single-use vials, Rx only, Manufactured for Cubist Pharmaceuticals, Inc., Lexington, MA
Distribution pattern
Nationwide
Recall initiation date
Aug 29, 2013
Initial firm notification
Letter
Center classification date
Jan 17, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-764-2014, published Jan 29, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls